Centrient
Sustainable leader in antibiotics, statins and anti-fungals
Centrient Pharmaceuticals is the global business-to-business leader in sustainable, enzymatic antibiotics, next-generation statins and anti-fungals. We produce and sell intermediates and active pharmaceutical ingredients (APIs), as well as our own tablets, capsules and other finished dosage forms (FDFs).
First established in 1869, our story has since been one of constant evolution and innovation. Today, we are a company 2,700-people strong with operations on four continents.
More than this, we are a pharmaceutical company with a clear mission: to improve lives by being at the centre of sustainable and accessible healthcare.
Our company has a common focus that unites each of us in our mission: across our global operations, we are committed to ensuring Quality, Reliability and Sustainability to customers, partners, patients and the world at large.
Moving forward, our vision is to be the leading, diversified and fully integrated partner to generics marketers.
Latest news
Planet B.io is a busy community, we are constantly developing and so are our collaborators, residents and members. To keep everyone updated we write articles and organise events. Take a look!
How Dutch Vocational Students Strengthen Industrial Biotechnology
Finding the right talent is a common challenge for biotech start-ups and scale-ups. While researchers are essential, hands-on laboratory technicians often make the real difference in day-to-day lab work. In this article, Rianne Veldt-Meijer from MBO Rijnland explains how MBO students gain research experience, where they add value for biotech companies, and why they may be the practical edge your lab needs.
VACANCY | Sales and Marketing Associate
Planet B.io is looking for a Sales and Marketing Associate to support and grow our community of start-ups, scale-ups, and corporates in the biotech and foodtech sector.
One year later: Insights from Scale-up frontrunners | Gianmarco Marino & Fer Klinckhamers (PlantOne Delft B.V.)
Gianmarco Marino and Fer Klinckhamers (Plant One Delft BV) share last year’s improvements and about their hidden treasure.
Fenneke Jolink